Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aurora Biosciences completes first stage of UHTSS for Warner-Lambert

Oct. 6, 1998

Merck KGaA, 3DP extend drug discovery agreement for another year

Oct. 5, 1998

Bayer, Millennium form the largest drug discovery alliance in history

Sep. 29, 1998

Tranzyme obtains technology license from U. of Alabama

Sep. 24, 1998

PowderJect delivery of DNA vaccines validated in preclinical study

Sep. 24, 1998

BTG licenses improved vaccine technology to Pasteur Merieux Connaught

Sep. 23, 1998

Lion and Infogen establish gene identification collaboration

Sep. 23, 1998

Genetronics reports continued success with electroporation therapy of cancer

Sep. 22, 1998

SB-234551 characterized as potent, selective, nonpeptide ETA receptor antagonist

Sep. 18, 1998

Nexell submits data requested by FDA

Sep. 18, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...